
Keywords: 2D; two-dimensional; AD; Alzheimer's disease; APP; amyloid precursor protein; FPP; farnesyl pyrophosphate; GGPP; geranylgeranyl pyrophosphate; GGT; geranylgeranyl transferase; GGTI; GGT inhibitor; HEPES; 4-(2-hydroxyethyl)-1-piperazineethanesulfonic aci